BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 26181651)

  • 1. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G; Brönnimann M; Hunziker T; Müller U
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
    Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
    Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
    Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
    Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
    Neis MM; Merk HF
    Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
    Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
    Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
    Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
    Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
    Zidarn M; Kosnik M; Drinovec I
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.